77 related articles for article (PubMed ID: 2921600)
1. Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A.
Reuman PD; Bernstein DI; Keely SP; Young EC; Sherwood JR; Schiff GM
J Med Virol; 1989 Feb; 27(2):137-41. PubMed ID: 2921600
[TBL] [Abstract][Full Text] [Related]
2. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
[TBL] [Abstract][Full Text] [Related]
3. Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition.
Reuman PD; Bernstein DI; Keely SP; Sherwood JR; Young EC; Schiff GM
Antiviral Res; 1990 Mar; 13(3):103-10. PubMed ID: 2353803
[TBL] [Abstract][Full Text] [Related]
4. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
Murphy BR; Phelan MA; Nelson DL; Yarchoan R; Tierney EL; Alling DW; Chanock RM
J Clin Microbiol; 1981 Mar; 13(3):554-60. PubMed ID: 7240388
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.
Sears SD; Clements ML
Antimicrob Agents Chemother; 1987 Oct; 31(10):1470-3. PubMed ID: 3435099
[TBL] [Abstract][Full Text] [Related]
6. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
Renegar KB; Small PA; Boykins LG; Wright PF
J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.
Reuman PD; Bernstein DI; Keefer MC; Young EC; Sherwood JR; Schiff GM
Antiviral Res; 1989 Feb; 11(1):27-40. PubMed ID: 2712549
[TBL] [Abstract][Full Text] [Related]
8. Serological diagnosis of influenza A/USSR/77 H1N1 infection: value of ELISA compared to other antibody techniques.
Van Voris LP; Betts RF; Menegus MA; Murphy BR; Roth FK; Douglas RG
J Med Virol; 1985 Aug; 16(4):315-20. PubMed ID: 3897451
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults.
Aoki FY; Stiver HG; Sitar DS; Boudreault A; Ogilvie RI
Clin Pharmacol Ther; 1985 Feb; 37(2):128-36. PubMed ID: 3967455
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
Cohen A; Togo Y; Khakoo R; Waldman R; Sigel M
J Infect Dis; 1976 Jun; 133 Suppl():A114-120. PubMed ID: 778307
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation.
Prevost JM; Vereerstraeten-Schmerber J; Lamy F; De Koster JP
Scand J Respir Dis; 1975 May; 56(1):58-69. PubMed ID: 1096297
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus.
Hayden FG; Hall WJ; Douglas RG
J Infect Dis; 1980 May; 141(5):535-42. PubMed ID: 7373086
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay for detection of serum or mucosal isotype-specific IgG and IgA whole-virus antibody to influenza A virus in swine.
Gauger PC; Loving CL; Vincent AL
Methods Mol Biol; 2014; 1161():303-12. PubMed ID: 24899439
[TBL] [Abstract][Full Text] [Related]
17. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.
Spencer MJ; Cherry JD; Terasaki PI
N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
20. [Immune response to influenza vaccination].
Alvarez I; Corral J; Arranz A; Foruria A; Landa V; Lejarza JR; Marijuán L; Martínez JM
Aten Primaria; 1989; 6(7):494, 496-9. PubMed ID: 2518952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
